— Know what they know.
Not Investment Advice

300255.SZ

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
1W: -4.2% 1M: -13.8% 3M: -30.7% YTD: -22.8% 1Y: +96.9% 3Y: +583.7% 5Y: +463.7%
¥36.71 ($5.32)
-0.21 (-0.57%)
 
SHZ · Healthcare · Biotechnology · ¥33.9B
Smart Money Score
Watch 0
Insider
Congress
ETF Holdings
Key Statistics
Market Cap¥33.9B ($4.9B)
52W Range15.75-71.71
Volume12,508,818
Avg Volume20,278,811
Beta0.12
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOXiaodong Gao
Employees1,410
SectorHealthcare
IndustryBiotechnology
IPO Date2011-08-19
Websiteheparin.cn
Zhengding County High-tech Ind Dev Zone
Shijiazhuang 050800
CN
83 311 8919 0181
About Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China. Its products include crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadra Heparin calcium raw materials, nadroparin calcium injections, and dalteparin sodium raw materials and injections. The company was founded in 2000 and is based in Shijiazhuang, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms